Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
Kähler KC, Gutzmer R, Angela Y, Livingstone E, Lodde G, Meiss F, Rafei-Shamsabadi DA, Weyer-Fahlbusch SS, Nashan D, Loquai C, Hassel JC, Sachse MMM, Maul LV, Heinzerling L, Heppt MV, Colapietro C, Rusch J, Blome C.
Kähler KC, et al. Among authors: rusch j.
J Cancer Res Clin Oncol. 2024 May 14;150(5):252. doi: 10.1007/s00432-024-05713-6.
J Cancer Res Clin Oncol. 2024.
PMID: 38743104
Free PMC article.